Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Morgan Stanley Adjusts Moderna PT to $337 From $190, Maintains Equal Weight Rating

09/07/2021 | 10:21am EDT


© MT Newswires 2021
All news about MODERNA, INC.
11:53aUS expected to authorize mix-and-match COVID booster shots
AQ
10:11aMODERNA : Germany may miss COVID-19 vaccine donation goal, blames manufacturers
RE
10:11aMODERNA : Germany may miss COVID-19 vaccine donation goal, blames manufacturers
RE
07:56aMODERNA : Germany may miss COVID-19 vaccine donation goal, blames manufacturers
RE
06:36aMODERNA : J&J keeps vaccine sales outlook unchanged after third-quarter miss
RE
04:28aFDA May Soon Allow Mix-and-Match COVID-19 Booster Shots
MT
10/18MODERNA : U.S. FDA to allow mixing and matching of COVID-19 boosters- NYT
RE
10/18MODERNA : U.S. FDA to allow mixing and matching of COVID-19 boosters- NYT
RE
10/18MODERNA : U.S. administers 408.8 mln doses of COVID-19 vaccines - CDC
RE
10/18ASTRAZENECA : EU has exported over 1 bln COVID-19 vaccines, von der Leyen says
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 335 M - -
Net income 2021 12 514 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 11,3x
Yield 2021 -
Capitalization 135 B 135 B -
EV / Sales 2021 6,01x
EV / Sales 2022 5,28x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 334,84 $
Average target price 299,31 $
Spread / Average Target -10,6%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.220.51%135 157
LONZA GROUP AG27.29%58 232
IQVIA HOLDINGS INC.38.67%47 608
SEAGEN INC.-1.81%31 287
CELLTRION, INC.-39.69%24 952
ALNYLAM PHARMACEUTICALS, INC.56.88%24 233